BioNTech SE
BNTX
$96.37
-$0.36-0.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 499.94% | 53.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 499.94% | 53.87% | |||
| Cost of Revenue | 99.96% | -1.68% | |||
| Gross Profit | 665.66% | 100.88% | |||
| SG&A Expenses | 11.33% | 22.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 2,899.57% | 48.12% | |||
| Total Operating Expenses | 129.20% | 11.08% | |||
| Operating Income | 92.22% | 4.74% | |||
| Income Before Tax | 106.32% | 2.49% | |||
| Income Tax Expenses | 441.67% | 41.34% | |||
| Earnings from Continuing Operations | 92.35% | -0.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 92.35% | -0.27% | |||
| EBIT | 92.22% | 4.74% | |||
| EBITDA | 124.36% | 7.89% | |||
| EPS Basic | 92.27% | 0.26% | |||
| Normalized Basic EPS | 111.16% | 3.01% | |||
| EPS Diluted | 92.27% | 0.26% | |||
| Normalized Diluted EPS | 111.16% | 3.01% | |||
| Average Basic Shares Outstanding | -1.02% | 0.53% | |||
| Average Diluted Shares Outstanding | -1.02% | 0.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||